White papers - all assets – Page 248
-
White papers
The day after #3 - ESG Resilience During the Covid Crisis: Is Green the New Gold?
Without a doubt, the coronavirus is shaking the financial industry like never before. This is not the first time the world has faced a pandemic of this scale, nor is the first time that policy makers, business leaders and pundits have asked: “Is it different this time around? Are we at a turning point?”
-
White papers
Risk (Modelling in Global Aggregate Portfolios) in a Time of COVID
John Beck, Director of Fixed Income contemplates how risk is measured in our portfolios.
-
White papers
The 20-Year Bond in a Brave New World
The US Government has responded to COVID-19 in unprecedented ways to produce a huge and rapid fiscal policy response. To fund this policy, the Treasury announced that it will issue over $800 billion in Treasury securities over the next three months. Including issuance completed in April, the issuance number rises to over $1 trillion. That is a massive issuance schedule. Here is what is upcoming.
-
White papers
The Stock Market Is Not the Economy
COVID-19 has damaged a lot of things, including the link between the S&P 500 and the U.S. economy.
-
White papers
Market Commentary - Swoosh Recovery vs. Liquidity Splash
The exit from the lockdowns is proceeding cautiously. If anything the number of new cases globally has picked up over the past week, flirting with 100k on 15 May, the highest since 16 April (see our latest Facts and Figures, including new modelling). Scientists keep warning about the risk of relaxing social distancing too quickly. In the meantime the global economy struggles – we slightly cut our 2020 global growth forecast from -3.5% to -4%. The risks are skewed to the downside. The WHO reiterated concerns about a deadlier second wave this autumn and winter.
-
White papers
What We Already Know About The Recovery
And why bonds and stocks may not be pricing in such different outcomes.
-
White papers
Investing in China: Consumers and technology recovering
This Equity Markets issue offers a window into post COVID-19 economic recovery.
-
White papers
Fixed Income: Health Uncertainty vs. Economic Uncertainty. The Need To Safely Restart Growth
Policymakers face difficult tradeoffs. Fixed Income Views explores macro and sector outlooks.
-
White papers
Quick Thoughts: A New Globalization Emerges
Our Head of Equities Stephen Dover gives his take on globalization in the wake of COVID-19
-
White papers
ESG & Factor Investing: a new stage has been reached
ESG Investing is evolving extremely rapidly, in Europe and abroad. The importance of taking into account environmental, social and governance factors in investment decisions has become more acute with the coronavirus. Past Amundi research has underlined that ESG integration has been a driver of alpha since 2014.
-
White papers
Corporate Responsibility | A Moment of Truth
Pushed to its very limits, mankind reveals its true nature. As the health, economic and market crisis unfolds, and at a time when maximizing profits and shareholder returns is no longer the priority, the sincerity of corporate responsibility is being put to test.
-
White papers
The trade-off between staying safe and getting back to work
An economy in lockdown has significant effects for investors in real assets. In this data illustration, our real assets research team consider the benefit of businesses returning to their usual locations against the risks of doing so.
-
White papers
Global Supply & Demand Curves Shift to the Left
U.S. inflation came in soft for April amid low oil prices and weak global demand. The employment report saw leisure and hospitality with the highest job losses, and Saudi Arabia announced plans to cut oil production again, easing concerns over storage capacity limits worldwide.
-
White papers
COVID-19 Science and Economics
In the second installment of our COVID-19 series, we discusses the scientific and economic implications of the path to recovery with research analyst Camilla Oxhamre Cruse, who has a Ph.D. in medicine and M.Sc. in biochemistry, and global strategist Olga Bitel.
-
White papers
What We Can Learn from China’s Rapid Normalization
China is further along the coronavirus curve than much of the rest of the world and is on a fast path toward normal. We think its experience bears close watching—not only because China is a major contributor to global economic activity, but also because there will likely be important takeaways for the rest of the world as other countries plan their own reopenings.
-
White papers
Will COVID-19 prove a watershed for ESG?
COVID-19 has thrown new light on the interdependencies in human and natural ecosystems, and the vulnerabilities of a closely networked world. Aviva Investors’ responsible investment specialists ask whether this will prove a turning point for environmental, social and governance issues.
-
White papers
The Historical Impact of Economic Downturns on Private Equity
An assessment of private equity return patterns in two recent significant downturns.
-
White papers
PE Investing at Market Inflections
Faced with the uncertainties of the COVID-19 crisis and demands for portfolio rebalancing, investors may be tempted to cut their private equity programs or re-think plans to expand them. In this short video interview, John Buser, Executive Vice Chairman—NB Alternatives, looks back to the dotcom era and the Great Financial Crisis to explain why he thinks they should stay the course.
-
White papers
Equity Investing as We Approach a “New Normal”
Richard Nackenson, Neuberger Berman Equity Senior Portfolio Manager, discusses how investor psychology has changed over the past month and where he is finding investment opportunities as we approach a “new normal.”
-
White papers
Coronavirus – weekly update – 13 May 2020
Worldwide COVID-19 cases crossed the 4.3 million mark and the death toll is closing in on 300,000 as of 13 May. The focus is now increasingly shifting to monitoring new cases and fatalities in a second wave that might follow hot on the heels of exit from lockdown.